Dr. Mason’s Experience Relevant to Cardiac Safety Consultation
Relevant Experience
Mason Cardiac Safety Consulting
Jay W. Mason, MD
Investigator in Early Phase Development of several antiarrhythmic drugs (tocainide, encainide, flecainide, amiodarone, primenol, sotalol, acebutalol, N-acetylprocainamide, diltiazem, imipramine, and bethanidine) and devices (Intermedics antitachycardia device series, Intec AICD, Medtronic implantable hemodynamic monitor)
Principal Investigator of multinational, NIH-funded clinical trials (ESVEM – Electrophysiologic Study Vs. Electrocardiographic Monitoring; MTT – the US Myocarditis Treatment Trial; SCOR - Specialized Center of Research in sudden Death)
Data and Safety Monitoring Boards for NIH-funded clinical trials (Member, Digitalis Mortality Trial; Chair, Antiarrhythmic Effects of N-3 Fatty Acids; Chair, Fatty Acid Arrhythmia Trial; Member, Periodontal Intervention in Cardiac Events; Chair, Resuscitation Consortium; Member, ResQ Trial; Member VEST Trial)
Electrocardiography Standards Setting Committees- (Chair, ECG-Self Assessment Program, American College of Cardiology [ACC]; Chair, ACC ECG Exam; Member, ACC Electrocardiography/ Electrophysiology/Electrocardiography Committee; Member, American Heart Association Electrocardiography Standardization Committee; Publications - Co-author, Guidelines for clinical intracardiac electrophysiologic studies - A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures; Co-author, Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures; Recommended guidelines for training in adult clinical cardiac electrophysiology. ACC Policy Statement; Author, American College of Cardiology Report on ECG Exam; Co-author, ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography; Author, AHA ECG Diagnostic Statement List)
Sponsor Support at FDA Meetings Multiple teleconference and face-to-face meeting with FDA on behalf of pharmaceutical companies since 1985
Core ECG Laboratory Medical Director,Covance Cardiac Safety Service, 2003 – 2007; Chief Medical Officer, Spaulding Clinical Research; consultant to pharma sponsors on drug development strategy, clinical trial design, expert analysis of cardiac safety data and interaction with FDA
Medical Device Developer Co-founder of Kardiatec, S.A., a medical device company developing the PULVAD, a ventricular assist device based upon the principle of counterpulsation; Co-inventor, Spaulding Electrocardiograph